(5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide

C31H29FN6O3 — CID 167529041

IUPAC(5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide
SMILESCC[C@H]1CCCn2nc(-c3ccc(C)nc3)c(C(=O)N[C@H]3N=C(c4ccccc4)c4cccc(F)c4NC3=O)c2O1
InChIInChI=1S/C31H29FN6O3/c1-3-21-11-8-16-38-31(41-21)24(26(37-38)20-15-14-18(2)33-17-20)29(39)36-28-30(40)35-27-22(12-7-13-23(27)32)25(34-28)19-9-5-4-6-10-19/h4-7,9-10,12-15,17,21,28H,3,8,11,16H2,1-2H3,(H,35,40)(H,36,39)/t21-,28+/m0/s1
InChIKeyPNIXHGWVMROGJR-RBTNQOKQSA-N
MW552.61 g/mol
LogP4.89
Rot. Bonds5

About (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide

(5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide (PubChem CID 167529041) has the molecular formula C31H29FN6O3 and a molecular weight of 552.61 g/mol. Its IUPAC name is (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide.

Molecular Properties

Compound Name(5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide
PubChem CID167529041
Molecular FormulaC31H29FN6O3
Molecular Weight552.61 g/mol
Exact Mass552.23
IUPAC Name(5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide
SMILESCC[C@H]1CCCn2nc(-c3ccc(C)nc3)c(C(=O)N[C@H]3N=C(c4ccccc4)c4cccc(F)c4NC3=O)c2O1
InChIInChI=1S/C31H29FN6O3/c1-3-21-11-8-16-38-31(41-21)24(26(37-38)20-15-14-18(2)33-17-20)29(39)36-28-30(40)35-27-22(12-7-13-23(27)32)25(34-28)19-9-5-4-6-10-19/h4-7,9-10,12-15,17,21,28H,3,8,11,16H2,1-2H3,(H,35,40)(H,36,39)/t21-,28+/m0/s1
InChIKeyPNIXHGWVMROGJR-RBTNQOKQSA-N
XLogP4.89
TPSA110.50 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500552.61
LogP ≤ 54.89
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide?
The IUPAC name of (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide (CID 167529041) is (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide.
What is the SMILES notation for (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide?
The canonical SMILES for (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide is CC[C@H]1CCCn2nc(-c3ccc(C)nc3)c(C(=O)N[C@H]3N=C(c4ccccc4)c4cccc(F)c4NC3=O)c2O1.
What is the InChIKey of (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide?
The InChIKey is PNIXHGWVMROGJR-RBTNQOKQSA-N. The full InChI is InChI=1S/C31H29FN6O3/c1-3-21-11-8-16-38-31(41-21)24(26(37-38)20-15-14-18(2)33-17-20)29(39)36-28-30(40)35-27-22(12-7-13-23(27)32)25(34-28)19-9-5-4-6-10-19/h4-7,9-10,12-15,17,21,28H,3,8,11,16H2,1-2H3,(H,35,40)(H,36,39)/t21-,28+/m0/s1.
What are the key properties of (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide?
(5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide has a molecular weight of 552.61 g/mol, XLogP of 4.89, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (5S)-5-ethyl-N-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(6-methyl-3-pyridinyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-3-carboxamide is sourced from PubChem (CID 167529041), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).